Skip to main content

Publications by Anna Månberg

Refereegranskade

Artiklar

[1]
A. Månberg et al., "Altered perivascular fibroblast activity precedes ALS disease onset," Nature Medicine, vol. 27, no. 4, 2021.
[2]
J. Dillner et al., "Antibodies to SARS-CoV-2 and risk of past or future sick leave," Scientific Reports, vol. 11, no. 1, 2021.
[3]
J. Remnestål et al., "Association of CSF proteins with tau and amyloid beta levels in asymptomatic 70-year-olds," Alzheimer's Research & Therapy, vol. 13, no. 1, 2021.
[5]
A. Jernbom Falk et al., "Autoantibody profiles associated with clinical features in psychotic disorders," Translational Psychiatry, vol. 11, no. 1, 2021.
[9]
H. Alkharaan et al., "Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19 : A Complementary Approach to Population Surveys," Journal of Infectious Diseases, vol. 224, no. 3, pp. 407-414, 2021.
[13]
J. Remnestål et al., "Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers," Translational Neurodegeneration, vol. 9, no. 1, 2020.
[15]
D. Just et al., "Exploring autoantibody signatures in brain tissue from patients with severe mental illness," Translational Psychiatry, vol. 10, no. 1, 2020.
[16]
A. Häggmark et al., "A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection," Molecular & Cellular Proteomics, vol. 18, no. 3, pp. 461-476, 2019.
[17]
A.-L. Lind et al., "CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia," Journal of Pain Research, vol. 12, pp. 2875-2889, 2019.
[20]
M. Uhlén et al., "The human secretome," Science Signaling, vol. 12, no. 609, 2019.
[21]
M. Garranzo-Asensio et al., "Identification of prefrontal cortex protein alterations in Alzheimer's Disease," OncoTarget, vol. 9, no. 13, pp. 10847-10867, 2018.
[22]
E. P. Thelin et al., "Protein profiling in serum after traumatic brain injury in rats reveals potential injury markers," Behavioural Brain Research, vol. 340, pp. 71-80, 2018.
[24]
A. Zandian et al., "Whole-Proteome Peptide Microarrays for Profiling Autoantibody Repertoires within Multiple Sclerosis and Narcolepsy," Journal of Proteome Research, vol. 16, no. 3, pp. 1300-1314, 2017.
[25]
P. E. Khoonsari et al., "Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease," PLOS ONE, vol. 11, no. 3, 2016.
[26]
A. Häggmark-Månberg et al., "Autoantibody targets in vaccine-associated narcolepsy," Autoimmunity, vol. 49, no. 6, pp. 421-433, 2016.
[27]
J. Remnestål et al., "CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease," PROTEOMICS - Clinical Applications, vol. 10, no. 12, pp. 1242-1253, 2016.
[29]
C. Fredolini et al., "Immunocapture strategies in translational proteomics," Expert Review of Proteomics, vol. 13, no. 1, pp. 83-98, 2016.
[30]
A. Häggmark, J. M. Schwenk and P. Nilsson, "Neuroproteomic profiling of human body fluids," PROTEOMICS - Clinical Applications, vol. 10, no. 4, pp. 485-502, 2016.
[32]
A. Häggmark et al., "Proteomic Profiling Reveals Autoimmune Targets in Sarcoidosis," American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 5, pp. 574-583, 2015.
[33]
S. Byström et al., "Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis," Journal of Proteome Research, vol. 13, no. 11, pp. 4607-4619, 2014.
[34]
F. E. Magraoui et al., "Developing new methods to answer old and new questions in neurodegenerative diseases," Proteomics, vol. 14, no. 11, pp. 1308-1310, 2014.
[35]
A. Häggmark et al., "Plasma profiling revelas three proteins associated to amyotrophic lateral sclerosis," Annals of Clinical and Translational Neurology, vol. 1, no. 8, pp. 544-553, 2014.
[36]
A. Häggmark et al., "Antibody-based profiling of cerebrospinal fluid within multiple sclerosis," Proteomics, vol. 13, no. 15, pp. 2256-2267, 2013.
[37]
B. Ayoglu et al., "Autoantibody profiling in multiple sclerosis using arrays of human protein fragments," Molecular & Cellular Proteomics, vol. 12, no. 9, pp. 2657-2672, 2013.
[38]
A. Häggmark et al., "Classification of protein profiles from antibody microarrays using heat and detergent treatment.," New Biotechnology, vol. 29, no. 5, pp. 564-570, 2011.
[39]
B. Ayoglu et al., "Systematic antibody and antigen-based proteomic profiling with microarrays," EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, vol. 11, no. 2, pp. 219-234, 2011.

Kapitel i böcker

[40]
E. Pin et al., "Array-based profiling of proteins and autoantibody repertoires in CSF," in Cerebrospinal Fluid (CSF) Proteomics, : Humana Press Inc., 2019, pp. 303-318.
[41]
A. Häggmark-Månberg, P. Nilsson and J. Schwenk, "Neuroproteomic profiling of cerebrospinal fluid (CSF) by multiplexed affinity arrays," in Neuroproteomics : Methods and Protocols, : Humana Press, 2017, pp. 247-254.

Icke refereegranskade

Artiklar

[43]
M. Persson et al., "Searching for Novel Autoantibodies with Clinical Relevance in Psychiatric Disorders," Schizophrenia Bulletin, vol. 44, pp. S120-S121, 2018.
[44]
D. Just et al., "Towards Molecular Insights Into Psychiatric Disorders Using Affinity Proteomics," Schizophrenia Bulletin, vol. 44, pp. S223-S223, 2018.

Avhandlingar

[45]
A. Häggmark, "Neuroproteomic profiling of human body fluids," Doctoral thesis Stockholm : KTH Royal Institute of Technology, TRITA-BIO-Report, 2015:2, 2015.
Senaste synkning med DiVA:
2021-10-16 01:01:41